Endocrine manifestations of hepatitis C virus infection

被引:87
作者
Antonelli, Alessandro [1 ]
Ferri, Clodoveo [2 ]
Ferrari, Silvia Martina
Colaci, Michele [2 ]
Sansonno, Domenico [3 ]
Fallahi, Poupak
机构
[1] Univ Pisa, Sch Med, Dept Internal Med, I-56100 Pisa, Italy
[2] Univ Modena, Dept Internal Med, I-41100 Modena, Italy
[3] Univ Bari, Dept Internal Med & Clin Oncol, I-70121 Bari, Italy
来源
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM | 2009年 / 5卷 / 01期
关键词
diabetes mellitus; hepatitis C virus; mixed cryoglobulinemia; thyroid autoimmunity; thyroid cancer; ALPHA-CHEMOKINE CXCL10; INDUCIBLE PROTEIN-10 LEVELS; CCL2; SERUM-LEVELS; THYROID-CANCER; MIXED CRYOGLOBULINEMIA; CORE PROTEIN; IFN-GAMMA; GLUCOSE-TOLERANCE; INTERFERON-ALPHA; HCV;
D O I
10.1038/ncpendmet1027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic infection with hepatitis C virus (HCV) can result in both hepatic and extrahepatic disease and endocrine dysfunction represents an important class of HCV-related extrahepatic disease. The most frequently occurring-and clinically important-of these endocrine disorders are thyroid disease and type 2 diabetes mellitus. In this Review, we evaluate the evidence in support of a link between HCV infection and endocrine-system dysfunction, and discuss potential pathophysiological mechanisms. A meta-analysis of the literature has revealed significant associations between chronic HCV infection, thyroid autoimmunity and hypothyroidism. Furthermore, a high prevalence of thyroid cancer has been reported in HCV-positive patients. Several clinicoepidemiological studies have demonstrated that chronic HCV infection could lead to the development of type 2 diabetes mellitus, possibly as a result of HCV-induced metabolic disturbances. Some researchers have postulated that a type 1 T-helper -cell mediated immune response underpins the association of chronic HCV infection with endocrine disease. Indeed, the available data suggest that a common immunological, type 1 T-helper cell pattern of cytokine expression and activation (via interferon-gamma) could provide the pathophysiological basis for this association. Nonetheless, additional studies will be necessary to elucidate fully all the mechanisms involved in HCV-related endocrine dysfunction.
引用
收藏
页码:26 / 34
页数:9
相关论文
共 64 条
[21]   Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection [J].
Bartolome, Javier ;
Rodriguez-Inigo, Elena ;
Quadros, Pedro ;
Vidal, Sonia ;
Pascual-Miguelanez, Isabel ;
Antonio Rodriguez-Montes, Jose ;
Garcia-Sancho, Luis ;
Carreno, Vicente .
JOURNAL OF MEDICAL VIROLOGY, 2008, 80 (09) :1588-1594
[22]   Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C [J].
Butera, D ;
Marukian, S ;
Iwamaye, AE ;
Hembrador, E ;
Chambers, TJ ;
Di Bisceglie, AM ;
Charles, ED ;
Talal, AH ;
Jacobson, IM ;
Rice, CM ;
Dustin, LB .
BLOOD, 2005, 106 (04) :1175-1182
[23]   Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C [J].
Cammà, C ;
Bruno, S ;
Di Marco, V ;
Di Bona, D ;
Rumi, M ;
Vinci, M ;
Rebucci, C ;
Cividini, A ;
Pizzolanti, G ;
Minola, E ;
Mondelli, MU ;
Colombo, M ;
Pinzello, G ;
Craxì, A .
HEPATOLOGY, 2006, 43 (01) :64-71
[24]   Hypothyroidism in transgenic mice expressing IFN-γ in the thyroid [J].
Caturegli, P ;
Hejazi, M ;
Suzuki, K ;
Dohan, O ;
Carrasco, N ;
Kohn, LD ;
Rose, NR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) :1719-1724
[25]   IP-10 and type 1 diabetes: A question of time and location [J].
Christen, U ;
Von Herrath, MG .
AUTOIMMUNITY, 2004, 37 (04) :273-282
[26]   Association of pretreatment serum interferon γ inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C [J].
Diago, M ;
Castellano, G ;
García-Samaniego, J ;
Pérez, C ;
Fernández, I ;
Romero, M ;
Iacono, OL ;
García-Monzón, C .
GUT, 2006, 55 (03) :374-379
[27]   Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection [J].
Duberg, AS ;
Nordström, M ;
Törner, A ;
Reichard, O ;
Strauss, R ;
Janzon, R ;
Bäck, E ;
Ekdahl, K .
HEPATOLOGY, 2005, 41 (03) :652-659
[28]   Hepatic steatosis: A benign disease or a silent killer [J].
El-Zayadi, Abdel-Rahman .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (26) :4120-4126
[29]  
Ferri C, 1997, INT J CANCER, V71, P1113, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1113::AID-IJC31>3.0.CO
[30]  
2-B